Drug recall · July 6, 2022
Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 count NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44, Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536
- Lots / codes
Lot # BLM2114A, exp. date 07/2023
- Quantity
- 84/1000 count bottles
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Product was distributed nationwide.
- Initiated
- June 10, 2022 · Voluntary: Firm initiated
- Classified
- June 27, 2022
- Reported
- July 6, 2022
- Ended
- May 23, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.